Literature DB >> 26415144

Percutaneous Renal Access: Surgical Factors Involved in the Acute Reduction of Renal Function.

Rajash K Handa1, Cynthia D Johnson1, Bret A Connors1, Andrew P Evan1, James E Lingeman2, Ziyue Liu3.   

Abstract

INTRODUCTION AND
OBJECTIVE: Studies in patients and experimental animals have shown that percutaneous nephrolithotomy (PCNL) can acutely impair glomerular filtration and renal perfusion, but the factors contributing to this decline in renal function are unknown. The present study assessed the contribution of needle puncture of the kidney vs dilation of the needle tract to the acute decline in renal hemodynamic and tubular transport function associated with PCNL surgery.
MATERIALS AND METHODS: Acute experiments were performed in three groups of anesthetized adult farm pigs: sham-percutaneous access (PERC), that is, no surgical procedure (n = 7); a single-needle stick to access the renal collecting system (n = 8); expansion of the single-needle access tract with a 30F NephroMax balloon dilator and insertion of a nephrostomy sheath (n = 10). The glomerular filtration rate (GFR), effective renal plasma flow (ERPF), and renal extraction of para-amino hippurate (EPAH, estimates tubular organic anion transporter [OAT] activity) were assessed before and 1 to 4.5 hours after sham-PERC or PERC surgical procedures.
RESULTS: Overall, GFR responses were similar in all three groups. Sham-treated PERC pigs showed no significant change in ERPF over the experimental observation period, whereas a single-needle stick to access the renal collecting system resulted in renal vasoconstriction (∼30% reduction in ERPF, p < 0.05). Dilation of the single-needle access tract to create the nephrostomy did not lead to a further decline in ERPF. PERC surgical procedure-mediated renal vasoconstriction was most evident at the 1-hour posttreatment time point. A reduction in EPAH was only observed in pig kidneys with a nephrostomy.
CONCLUSIONS: Needle puncture of the kidney for percutaneous access to the renal collecting system is the major driving force for the renal vasoconstriction observed after PCNL surgery, whereas creation of the nephrostomy appears to be largely responsible for decreasing tubular OAT activity.

Entities:  

Mesh:

Year:  2015        PMID: 26415144      PMCID: PMC4761855          DOI: 10.1089/end.2015.0542

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  22 in total

1.  Renal nerves mediate changes in contralateral renal blood flow after extracorporeal shockwave lithotripsy.

Authors:  Bret A Connors; Andrew P Evan; Lynn R Willis; Jay R Simon; Naomi S Fineberg; David A Lifshitz; Arieh L Shalhav; Ryan F Paterson; Ramsay L Kuo; James E Lingeman
Journal:  Nephron Physiol       Date:  2003

2.  Effect of multiple access tracts during percutaneous nephrolithotomy on renal function: evaluation of risk factors for renal function deterioration.

Authors:  Amr S Fayad; Mohamed G Elsheikh; Ashraf Mosharafa; Ragheb El-Sergany; Mohammed A Abdel-Rassoul; Ahmed Elshenofy; Hisham Ghamrawy; Ahmed Abd El Bary; Tarek Fayad
Journal:  J Endourol       Date:  2014-03-24       Impact factor: 2.942

3.  Effect of percutaneous nephrostolithotomy on renal function.

Authors:  M E Mayo; J N Krieger; T G Rudd
Journal:  J Urol       Date:  1985-02       Impact factor: 7.450

4.  Late sequelae of ultrasonic lithotripsy of renal calculi.

Authors:  M Marberger; W Stackl; W Hruby; A Kroiss
Journal:  J Urol       Date:  1985-02       Impact factor: 7.450

5.  Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats.

Authors:  R Schneider; C Sauvant; B Betz; M Otremba; D Fischer; H Holzinger; C Wanner; J Galle; M Gekle
Journal:  Am J Physiol Renal Physiol       Date:  2007-01-23

Review 6.  Neural regulation of renin secretion.

Authors:  U C Kopp; G F DiBona
Journal:  Semin Nephrol       Date:  1993-11       Impact factor: 5.299

7.  The effects of intraoperative infusion of dexmedetomidine on early renal function after percutaneous nephrolithotomy.

Authors:  A Bayram; A Esmaoglu; A Akin; G Baskol; R Aksu; C Bicer; A Demirtas; R Mutluay; A Boyaci
Journal:  Acta Anaesthesiol Scand       Date:  2011-05       Impact factor: 2.105

8.  Renal functional effects of simultaneous bilateral single-tract percutaneous access in pigs.

Authors:  Rajash K Handa; Cynthia D Johnson; Bret A Connors; Sujuan Gao; Andrew P Evan; Nicole L Miller; Brian R Matlaga; James E Lingeman
Journal:  BJU Int       Date:  2009-06-02       Impact factor: 5.588

Review 9.  The molecular and cellular physiology of basolateral organic anion transport in mammalian renal tubules.

Authors:  William H Dantzler; Stephen H Wright
Journal:  Biochim Biophys Acta       Date:  2003-12-30

10.  Time-course for recovery of renal function after unilateral (single-tract) percutaneous access in the pig.

Authors:  Rajash K Handa; Lynn R Willis; Bret A Connors; Sujuan Gao; Andrew P Evan; Samuel C Kim; William W Tinmouth; James E Lingeman
Journal:  J Endourol       Date:  2010-02       Impact factor: 2.942

View more
  3 in total

1.  Baseline chronic kidney disease does not predict long-term renal functional decline after percutaneous nephrolithotomy.

Authors:  Kara L Watts; Abhishek Srivastava; Wilson Lin; Daniel Schoenfeld; Matthew Abramowitz; Joshua M Stern
Journal:  Urolithiasis       Date:  2019-02-12       Impact factor: 3.436

2.  Postoperative Renal Outcomes of Patients Receiving Percutaneous Nephrolithotomy versus Pyelolithotomy: A Population-Based Cohort Study.

Authors:  Fang-Ting Chen; Fu-Chao Liu; Chih-Wen Cheng; Jr-Rung Lin; Huang-Ping Yu
Journal:  Biomed Res Int       Date:  2018-05-02       Impact factor: 3.411

3.  A novel spherical-headed fascial dilator is feasible for second-stage ultrasound guided percutaneous nephrolithotomy: A pilot study.

Authors:  Yiwei Wang; Liheng Gao; Mingxi Xu; Wenfeng Li; Yuanshen Mao; Fujun Wang; Lu Wang; Jun Da; Zhong Wang
Journal:  Asian J Urol       Date:  2021-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.